Shandong Science ›› 2021, Vol. 34 ›› Issue (4): 26-33.doi: 10.3976/j.issn.1002-4026.2021.04.005

• Traditional Chinese medicine and natural active products • Previous Articles     Next Articles

Quality control of berberine and leonurine in Lishitonglin Granules

YUAN Min, LIANG Rui-xue*, LIU Qing   

  1. Shandong Academy of Chinese Medicine,Jinan 250014China
  • Received:2020-11-10 Published:2021-07-30 Online:2021-07-30

Abstract: A quality control method to quantify berberine and leonurine in Lishitonglin Granules via HPLC was established.The content of berberine was determined using the Diamonsil-C18 chromatographic column (250 mm×4.6 mm,5 μm) and acetonitrile-0.1% phosphoric acid(50:50,V/V)solution with 0.1 g sodium dodecyl sulfate per 100 mL of the solution as the mobile phase. The flow rate was 1.0 mL/min, and the detection wavelength was 265 nm. The content of leonurine was determined using the Diamonsil-C18 chromatographic column(250 mm×4.6 mm,5 μm).The mobile phase was acetonitrile-0.1% phosphoric acid solution (24:76, V/V) containing 0.4% sodium octane sulfonate. The flow rate was 1.0 mL/min, and the detection wavelength was 277 nm. The results showed that berberine was linear in the range of 0.052~0.520 μg(r=0.999 6) and leonurine was linear in the range of 0.039 6~0.396 0 μg (r=0.999 1). Further, there was a good linear relationship between injection volume and peak area. The recovery rate of berberine was 98.51%~102.1%, with relative standard deviation(RSD) of 2.08% (n=6).The recovery rate of leonurine was 99.90%~102.6%, with RSD of 1.13% (n=6). The established method has high specificity, good reproducibility, and ease of operation and can be used for the quality control analysis of Lishitonglin Granules.

Key words: Lishitonglin Granules, berberine, leonurine; quality control, HPLC

CLC Number: 

  • R284.2

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0